February 11, 2026 07:06 am (IST)

Make this your homepage

Health

Bangladesh poll manifestos mirror India’s welfare schemes as BNP, Jamaat bet big on women, freebies | Drama ends: Pakistan makes U-turn on India boycott, to play T20 World Cup clash as per schedule | ‘Won’t allow any impediment in SIR’: Supreme Court pulls up Mamata govt over delay in sharing officers’ details | India-US trade deal: ‘Negotiations always two-way’, says Amul MD amid farmers’ concerns | Khamenei breaks 37-year-old ritual for first time amid escalating Iran-US tensions | India must push for energy independence amid global uncertainty: Vedanta chairman Anil Agarwal | Kanpur horror: Lamborghini driven by businessman’s son rams vehicles, injures six | ‘Namaste Trump beat Howdy Modi’: Congress slams PM Over India-US trade deal | Historic India-US trade pact: Tariffs cut, $500B market opportunity unlocked! | Big call from RBI: Repo rate stays at 5.25%, neutral stance continues

Cervical Cancer Vax

Image Credit: Wallpaper Cave

India's first indigenously developed cervical cancer vaccine launched

India Blooms News Service | @indiablooms | Sep 02, 2022, at 06:47 am

#SerumInstitute #HPV #CervicalCancer #CervicalCancerVaccine

The Serum Institute of India (SII) and the Department of Biotechnology (DBT) Thursday officially announced India's first indigenous vaccine for cervical cancer.

Union Minister of Science and Technology Jitendra Singh along with SII CEO Adar Poonawalla launched the vaccine at IIC Delhi.

Historic milestone in Preventive Healthcare,under leadership of PM Sh @NarendraModi.
India’s first indigenously developed Quadrivalent Human Papillomavirus vaccine (qHPV) against Cervical Cancer launched by Department of Biotechnology under Union Ministry of Science & Technology pic.twitter.com/EItvwgVX9J
— Dr Jitendra Singh (@DrJitendraSingh) September 1, 2022

Drugs Controller General of India (DCGI) granted market authorisation for the jibe in July.

For the first time there will be an Indian HPV vaccine to treat cervical cancer in women that is both affordable and accessible. We look forward to launching it later this year and we thank the #DCGI @MoHFW_INDIA for granting approval today.
— Adar Poonawalla (@adarpoonawalla) July 12, 2022

As many as 42 lakh women have died due to this disease in India since 2019, according to World Health Organisation (WHO) data. It is the second most frequent cancer among women in the age group between 15 to 44.

The HPV vaccine protects against the types of HPV that most often cause cervical, vaginal, and vulvar cancers.

The vaccine may be priced between Rs 200-400 but it's not finalised yet, SII CEO, Adar Poonawalla said. The company plans to manufacture 200 million doses in 2 years.

The government may launch the vaccine under the National Immunisation programme for 9-14-year-old girls in the next few months.

An indigenous, affordable Vaccine against Cervical Cancer marks an important breakthrough for Department of Biotechnology under Union Ministry of Science & Technology, taking India a step closer to PM Sh @narendraModi’s vision of preventive healthcare in #AtmanirbharBharat. pic.twitter.com/92wiGY7EEL
— Dr Jitendra Singh (@DrJitendraSingh) September 1, 2022

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.